Drug Type Small molecule drug |
Synonyms MyVaccx, YourVaccx, BLD110 + [8] |
Target |
Action inhibitors, stimulants |
Mechanism Chk inhibitors(Checkpoint kinase inhibitors), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Prostatic Cancer | Phase 1 | United States | - | - |
| Prostatic Cancer | Phase 1 | - | - | |
| Bladder Cancer | Preclinical | United States | - | 25 Jul 2019 |
| Pancreatic Cancer | Preclinical | United States | - | 25 Jul 2019 |
| Ovarian Cancer | Preclinical | United States | - | 22 Jul 2019 |
| Small Cell Lung Cancer | Preclinical | United States | - | 27 Jun 2019 |
| Melanoma | Preclinical | United States | - | 26 Jun 2019 |
| Breast Cancer | Preclinical | United States | - | 15 Jun 2019 |
| Brain Cancer | Preclinical | United States | - | 07 Jun 2019 |





